Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Oral Oncology Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S277290602400476X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553664374734848 |
|---|---|
| author | J. Nandhini E. Karthikeyan |
| author_facet | J. Nandhini E. Karthikeyan |
| author_sort | J. Nandhini |
| collection | DOAJ |
| format | Article |
| id | doaj-art-3bdcf4b3394e4c7f8147db469347ce7d |
| institution | Kabale University |
| issn | 2772-9060 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Oral Oncology Reports |
| spelling | doaj-art-3bdcf4b3394e4c7f8147db469347ce7d2025-01-09T06:16:59ZengElsevierOral Oncology Reports2772-90602024-09-0111100630Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinomaJ. Nandhini0E. Karthikeyan1Corresponding author. Department of Pharmaceutics, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105, Tamilnadu, India.; Department of Pharmaceutics, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 602105, IndiaDepartment of Pharmaceutical Chemistry, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 602105, Indiahttp://www.sciencedirect.com/science/article/pii/S277290602400476X |
| spellingShingle | J. Nandhini E. Karthikeyan Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma Oral Oncology Reports |
| title | Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma |
| title_full | Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma |
| title_fullStr | Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma |
| title_full_unstemmed | Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma |
| title_short | Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma |
| title_sort | nivolumab opdivo in pd 1 pathway inhibition enhancing immune response in recurrent oral squamous cell carcinoma |
| url | http://www.sciencedirect.com/science/article/pii/S277290602400476X |
| work_keys_str_mv | AT jnandhini nivolumabopdivoinpd1pathwayinhibitionenhancingimmuneresponseinrecurrentoralsquamouscellcarcinoma AT ekarthikeyan nivolumabopdivoinpd1pathwayinhibitionenhancingimmuneresponseinrecurrentoralsquamouscellcarcinoma |